Covid-19 guidance update – November 2021
This page collates new guidance and existing guidance that has been updated since our last newsletter on 20 October.
Covid-19 response guidance
- Revised UK infection prevention and control guidance, published 24.11.2021
- EU DCC (European Union Digital Covid Certificate), published 2.11.2021.
- Winter preparedness in the NHS, published 25.10.2021.
Covid vaccination guidance
- National protocol for Covid-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]), updated to version 5, 29.11.2021.
- Patient Group Direction for Covid-19 Vaccine AstraZeneca, (ChAdOx1-S [recombinant]), updated 29.11.2021.
- Frequently asked questions (FAQs): ensuring NHS staff deployed into CQC-registered care homes have had the Covid-19 vaccination or are exempt, updated 29.11.2021.
- Third primary Covid-19 vaccine dose for eligible cancer patients, published 23.11.2021
- Covid-19 vaccination: a guide to a second dose for young people aged 16 to 17, updated 22.11.2021.
- Covid-19 vaccination programme for children and young people: guidance for schools (version 2), updated 22.11.2021
- National protocol for Covid-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) and National protocol for Comirnaty® Covid-19 mRNA vaccine, updated to version 3.0, 22.11.2021.
- Patient Group Direction for Covid-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) and Patient group direction for Comirnaty® (Pfizer BioNTech), updated 19.11.2021.
- Covid-19 vaccination: a guide to booster vaccination for individuals aged 40 years and over, published 17.11.2021.
- Covid-19: the green book, chapter 14a, booster vaccine info updated, 15.11.2021.
Contract documents
- Network Contract Directed Enhanced Service – Contract Specification 2021/22 – PCN Requirements and Entitlements, updated 18.11.2021.
Covid-19 antiviral pilots (16 Dec 2021)
The government announced this month that thousands of the UK’s most vulnerable people will be among the first in the world to access a new antiviral treatment for Covid-19, Molnupiravir....Registering overseas vaccinations at vaccination sites (16 Dec 2021)
On 9 December the Government updated guidance advising patients who wish to add an overseas Covid-19 vaccination to their NHS record to do so by booking a specific type of...Guidance updates December 2021 (16 Dec 2021)
The most important pieces of guidance released for general practice since our last newsletter are: Regulatory approval of Pfizer/BioNTech vaccine for COVID-19 and Regulatory approval of Spikevax...PCSE updates on contact details and pooled lists (16 Dec 2021)
Correct contact details Practices can improve communications with PCSE by ensuring that they have the most up to date practice contact details, including: The main practice contact All user...MP engagement and government consultations (16 Dec 2021)
During late November and December 2021 representatives from Londonwide LMCs have continued to meet with MPs, councillors and the police to raise issues affecting practices. We have also submitted evidence...Tips of the month December 2021 (16 Dec 2021)
We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...Dr Michelle Drage’s Christmas and New Year message (16 Dec 2021)
Thank you for simply still being here after the year you and all London general practices have had. With relentless pressure coming from clinically necessary activity, and the equally relentless...Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd (16 Dec 2021)
The Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd will be held on Thursday 20 January 2022 between 2:00pm and 3.15pm. The AGM is a chance to meet...Londonwide LMCs' December 2021 Newsletter (16 Dec 2021)
Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.
follow us on...
